
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Toll-Like Receptor Agonists in Cancer Therapy
Sylvia Adams
Immunotherapy (2009) Vol. 1, Iss. 6, pp. 949-964
Open Access | Times Cited: 285
Sylvia Adams
Immunotherapy (2009) Vol. 1, Iss. 6, pp. 949-964
Open Access | Times Cited: 285
Showing 1-25 of 285 citing articles:
Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria, Encouse B. Golden, Silvia C. Formenti
JAMA Oncology (2015) Vol. 1, Iss. 9, pp. 1325-1325
Closed Access | Times Cited: 650
Sandra Demaria, Encouse B. Golden, Silvia C. Formenti
JAMA Oncology (2015) Vol. 1, Iss. 9, pp. 1325-1325
Closed Access | Times Cited: 650
Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention
Anna Aiello, Farzin Farzaneh, Giuseppina Candore, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 602
Anna Aiello, Farzin Farzaneh, Giuseppina Candore, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 602
Oncolytic viruses as engineering platforms for combination immunotherapy
Kwame Twumasi‐Boateng, Jessica L. Pettigrew, Young Kwok, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 7, pp. 419-432
Closed Access | Times Cited: 358
Kwame Twumasi‐Boateng, Jessica L. Pettigrew, Young Kwok, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 7, pp. 419-432
Closed Access | Times Cited: 358
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Thiago A. Patente, Mariana Pereira Pinho, Aline A. Oliveira, et al.
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 346
Thiago A. Patente, Mariana Pereira Pinho, Aline A. Oliveira, et al.
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 346
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal, Anna Sokolovska, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 316
Daniel S. Leventhal, Anna Sokolovska, Ning Li, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 316
TLR agonists: our best frenemy in cancer immunotherapy
Sabina Kaczanowska, Ann Mary Joseph, Eduardo Dávila
Journal of Leukocyte Biology (2013) Vol. 93, Iss. 6, pp. 847-863
Open Access | Times Cited: 315
Sabina Kaczanowska, Ann Mary Joseph, Eduardo Dávila
Journal of Leukocyte Biology (2013) Vol. 93, Iss. 6, pp. 847-863
Open Access | Times Cited: 315
The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 258
Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 258
A novel multi-epitope peptide vaccine against cancer: An in silico approach
Navid Nezafat, Younes Ghasemi, Gholamreza Javadi, et al.
Journal of Theoretical Biology (2014) Vol. 349, pp. 121-134
Closed Access | Times Cited: 226
Navid Nezafat, Younes Ghasemi, Gholamreza Javadi, et al.
Journal of Theoretical Biology (2014) Vol. 349, pp. 121-134
Closed Access | Times Cited: 226
Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
Marion Dajon, Kristina Iribarren, Isabelle Cremer
Immunobiology (2016) Vol. 222, Iss. 1, pp. 89-100
Closed Access | Times Cited: 187
Marion Dajon, Kristina Iribarren, Isabelle Cremer
Immunobiology (2016) Vol. 222, Iss. 1, pp. 89-100
Closed Access | Times Cited: 187
Activating a collaborative innate-adaptive immune response to control metastasis
Lijuan Sun, Tim Kees, Ana S. Almeida, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1361-1374.e9
Open Access | Times Cited: 186
Lijuan Sun, Tim Kees, Ana S. Almeida, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1361-1374.e9
Open Access | Times Cited: 186
Gut Microbiota Shapes the Efficiency of Cancer Therapy
Weidong Ma, Qixing Mao, Wenjie Xia, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 161
Weidong Ma, Qixing Mao, Wenjie Xia, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 161
A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
Yanxian Feng, Ruoyu Mu, Zhenzhen Wang, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 145
Yanxian Feng, Ruoyu Mu, Zhenzhen Wang, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 145
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 85
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 85
Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans
Chunjian Qi, Yihua Cai, Lacey Gunn, et al.
Blood (2011) Vol. 117, Iss. 25, pp. 6825-6836
Open Access | Times Cited: 219
Chunjian Qi, Yihua Cai, Lacey Gunn, et al.
Blood (2011) Vol. 117, Iss. 25, pp. 6825-6836
Open Access | Times Cited: 219
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
Sylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 24, pp. 6748-6757
Open Access | Times Cited: 207
Sylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 24, pp. 6748-6757
Open Access | Times Cited: 207
Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
Xiaosong Li, Min Min, Nan Du, et al.
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-8
Open Access | Times Cited: 192
Xiaosong Li, Min Min, Nan Du, et al.
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-8
Open Access | Times Cited: 192
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Valerie Chew, Han Chong Toh, Jean‐Pierre Abastado
Journal of Oncology (2012) Vol. 2012, pp. 1-10
Open Access | Times Cited: 190
Valerie Chew, Han Chong Toh, Jean‐Pierre Abastado
Journal of Oncology (2012) Vol. 2012, pp. 1-10
Open Access | Times Cited: 190
Cancer and Innate Immune System Interactions
Yanan Liu, Gang Zeng
Journal of Immunotherapy (2012) Vol. 35, Iss. 4, pp. 299-308
Open Access | Times Cited: 171
Yanan Liu, Gang Zeng
Journal of Immunotherapy (2012) Vol. 35, Iss. 4, pp. 299-308
Open Access | Times Cited: 171
Toll-Like Receptor Agonists
Sacha Gnjatic, Nikhil B. Sawhney, Nina Bhardwaj
The Cancer Journal (2010) Vol. 16, Iss. 4, pp. 382-391
Open Access | Times Cited: 156
Sacha Gnjatic, Nikhil B. Sawhney, Nina Bhardwaj
The Cancer Journal (2010) Vol. 16, Iss. 4, pp. 382-391
Open Access | Times Cited: 156
Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation
James Q. Wang, Yogesh Jeelall, Laura L. Ferguson, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 153
James Q. Wang, Yogesh Jeelall, Laura L. Ferguson, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 153
Science gone translational: the OX40 agonist story
Andrew D. Weinberg, Nicholas P. Morris, Magdalena Kovacsovics‐Bankowski, et al.
Immunological Reviews (2011) Vol. 244, Iss. 1, pp. 218-231
Open Access | Times Cited: 152
Andrew D. Weinberg, Nicholas P. Morris, Magdalena Kovacsovics‐Bankowski, et al.
Immunological Reviews (2011) Vol. 244, Iss. 1, pp. 218-231
Open Access | Times Cited: 152
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
Md. Zahidunnabi Dewan, Claire Vanpouille‐Box, Noriko Kawashima, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 24, pp. 6668-6678
Open Access | Times Cited: 146
Md. Zahidunnabi Dewan, Claire Vanpouille‐Box, Noriko Kawashima, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 24, pp. 6668-6678
Open Access | Times Cited: 146
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Maria Shatz, Daniel Menéndez, Michael A. Resnick
Cancer Research (2012) Vol. 72, Iss. 16, pp. 3948-3957
Open Access | Times Cited: 134
Maria Shatz, Daniel Menéndez, Michael A. Resnick
Cancer Research (2012) Vol. 72, Iss. 16, pp. 3948-3957
Open Access | Times Cited: 134
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
Bayard R. Huck, Lisa Kötzner, Klaus Urbahns
Angewandte Chemie International Edition (2017) Vol. 57, Iss. 16, pp. 4412-4428
Open Access | Times Cited: 133
Bayard R. Huck, Lisa Kötzner, Klaus Urbahns
Angewandte Chemie International Edition (2017) Vol. 57, Iss. 16, pp. 4412-4428
Open Access | Times Cited: 133